Showing results (1-10 of 68) with videos related to
Sort By:
Pageof 7
American Journal of Clinical Oncology|August 2, 2002
Hypertriglyceridemia and pancreatitis associated with estramustine phosphateEric L Olson, Young E WhangInvestigational New Drugs|December 4, 2014
Posterior reversible encephalopathy syndrome induced by enzalutamide in a patient with castration-resistant prostate cancerDaniel J Crona, Young E WhangOncogene|January 23, 2002
PTEN sensitizes prostate cancer cells to death receptor-mediated and drug-induced apoptosis through a FADD-dependent pathwayXiu-Juan Yuan, Young E WhangCancers|June 13, 2017
Androgen Receptor-Dependent and -Independent Mechanisms Involved in Prostate Cancer Therapy ResistanceDaniel J Crona, Young E WhangExpert Review of Anticancer Therapy|June 15, 2014
Mechanisms of acquired resistance to androgen receptor targeting drugs in castration-resistant prostate cancerDavid D Chism, Dinuka De Silva, Young E WhangAnti-Cancer Drugs|March 2, 2011
Response to degarelix after resistance to luteinizing hormone-releasing hormone agonist therapy for metastatic prostate cancerRyan S Raddin, Christine M Walko, Young E WhangInvestigational New Drugs|June 30, 2018
Cabozantinib-induced serum creatine kinase elevation and musculoskeletal complaintsSarah E Stump, Young E Whang, Daniel J CronaMolecular Cancer Therapeutics|August 27, 2003
Rapamycin inhibits telomerase activity by decreasing the hTERT mRNA level in endometrial cancer cellsChunxiao Zhou, Paola A Gehrig, Young E Whang, et al.Cancer Research|November 17, 2005
Activated tyrosine kinase Ack1 promotes prostate tumorigenesis: role of Ack1 in polyubiquitination of tumor suppressor WwoxNupam P Mahajan, Young E Whang, James L Mohler, et al.Pageof 7